Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 111.03
-7.17 (-6.07%)
At close: Feb 27, 2026
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.09 billion as of February 27, 2026. Its market cap has increased by 165.07% in one year.
Market Cap
1.09B
Enterprise Value
997.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
111.03
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.09B, an increase of 1,937.43%. That is a compound annual growth rate of 81.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.09B | 26.37% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 669.80M |
| NervGen Pharma | 426.12M |
| Satellos Bioscience | 350.86M |
| Helix BioPharma | 150.46M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 62.62M |